kabutan

3-D Matrix,Ltd.(7777) Summary

7777
TSE Growth
3-D Matrix,Ltd.
438
JPY
+10
(+2.34%)
Jan 29, 1:14 pm JST
2.86
USD
Jan 28, 11:15 pm EST
Result
PTS
outside of trading hours
438.6
Jan 29, 1:15 pm JST
Summary Chart Historical News Financial Result
PER
176.6
PBR
15.3
Yield
ー%
Margin Trading Ratio
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
429 JPY 2.80 USD
Previous Close Jan 28
428 JPY 2.80 USD
High Jan 29, 12:57 pm
444 JPY 2.90 USD
Low Jan 29, 9:01 am
423 JPY 2.76 USD
Volume
1,965,400
Trading Value
0.85B JPY 5.60M USD
VWAP
434.69 JPY 2.84 USD
Minimum Trading Value
43,800 JPY 286 USD
Market Cap
0.05T JPY 0.35B USD
Number of Trades
1,227
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
High
1-Year Average
1,562
1-Year High Sep 16, 2025
16,543
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 600 14,148,100 23580.17
Jan 16, 2026 21,100 13,838,100 655.83
Jan 9, 2026 0 15,649,900
Dec 26, 2025 5,100 15,736,700 3085.63
Dec 19, 2025 15,800 17,237,500 1090.98
Company Profile
3-D Matrix, Ltd. is a bioventure company that develops medical products by applying peptide technology. The company operates both domestically and internationally.
Sector
Precision Instruments
3-D Matrix, Ltd. conducts research and development, manufacturing, and sales of medical devices and pharmaceuticals based on self-assembling peptide technology, for which it has obtained an exclusive license from MIT. The company's main development pipeline includes absorbable local hemostatic agents for surgical applications, mucosal lifting agents, post-bleeding prevention materials, adhesion prevention materials, wound healing materials for tissue regeneration, alveolar bone reconstruction materials, and drug delivery systems (DDS) for nucleic acid therapeutics. 3-D Matrix has established direct sales systems in the United States, Japan, and Australia, while also conducting sales through partner companies in some regions.